Compare $GTBP vs $TPST | Chartloom

Compare

$GTBP vs $TPST

GT Biopharma Inc · Tempest Therapeutics Inc

GTBP

GT Biopharma Inc

TPST

Tempest Therapeutics Inc

Compare $GTBP vs $TPST

Comparing GT Biopharma Inc and Tempest Therapeutics Inc

GTBPGT Biopharma Inc

TPSTTempest Therapeutics Inc

GTBPGT Biopharma Inc

Market cap

$296M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-75.3%

FCF yield

-4.9%

TPSTTempest Therapeutics Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-6.3%

YTD performance

-74.2%

52W performance

-93.1%

FCF yield

-170.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTBP

TPST

Detailed metrics comparison

GTBP

GT Biopharma Inc

TPST

Tempest Therapeutics Inc

Market Cap

GTBP$296M

TPST$12M

Enterprise Value

GTBP$291M

TPST$11M

Price

GTBP$6.68

TPST$0.76

P/E Ratio

GTBPN/A

TPSTN/A

P/S Ratio

GTBP174.71x

TPST45.67x

EV/Sales

GTBP95.98x

TPST43.07x

EV/EBITDA

GTBP0.00x

TPST0.00x

P/B Ratio

GTBP3.08x

TPST16.67x

P/FCF Ratio

GTBPN/A

TPSTN/A

EV/FCF

GTBP-20.19x

TPST-0.55x

PEG Ratio

GTBPN/A

TPSTN/A

Forward P/E (NTM)

GTBPN/A

TPSTN/A

Forward P/S (NTM)

GTBPN/A

TPSTN/A

Revenue (TTM)

GTBP$0

TPST$0

Revenue Growth (YoY)

GTBPN/A

TPST-6.3%

Forward Rev Growth

GTBP216.5%

TPST0.0%

Gross Margin (TTM)

GTBP36.5%

TPST0.0%

Operating Margin (TTM)

GTBP0.0%

TPST0.0%

EBITDA Margin (TTM)

GTBP0.0%

TPST0.0%

Net Margin (TTM)

GTBP0.0%

TPST0.0%

FCF Margin (TTM)

GTBPN/A

TPSTN/A

Net Income (TTM)

GTBP$-33M

TPST$-40M

FCF (TTM)

GTBP$-14M

TPST$-21M

EPS (TTM)

GTBP-$21.10

TPST-$2.66

ROE (TTM)

GTBP-44308.0%

TPST-72989.0%

ROA (TTM)

GTBP-31311.0%

TPST-29736.0%

ROIC (TTM)

GTBP-44308.0%

TPST-72989.0%

Cash

GTBP$5M

TPST$779K

Debt

GTBP$0

TPST$0

Net Cash/Debt

GTBP$5M

TPST$779K

Current Ratio (TTM)

GTBP2.61x

TPST0.38x

Quick Ratio (TTM)

GTBP2.51x

TPST0.27x

Debt/Equity (TTM)

GTBP0.00x

TPST0.00x

Debt/Assets (TTM)

GTBP0.0%

TPST0.0%

Interest Coverage (TTM)

GTBPN/A

TPSTN/A

Net Debt/EBITDA (TTM)

GTBP0.00x

TPST0.00x

Beta

GTBP0.81

TPST-1.61

52W Performance

GTBP-75.3%

TPST-93.1%

YTD Performance

GTBP-67.3%

TPST-74.2%

% from 52W High

GTBP-76.8%

TPST-93.8%

% from 52W Low

GTBP36.0%

TPST2.3%

Asset Turnover (TTM)

GTBP0.08x

TPST0.01x

FCF Yield (TTM)

GTBP-4.9%

TPST-170.7%

Earnings Yield (TTM)

GTBP-11.1%

TPST-333.2%

Dividend Yield (TTM)

GTBPN/A

TPSTN/A

Rule of 40

GTBP0.0

TPST-6.3

EV/GP/RG

GTBPN/A

TPSTN/A

Ticker research

View GTBP research View TPST research

Metric	GTBP GT Biopharma Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$296M	$12M
Enterprise Value	$291M	$11M
Price	$6.68	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	174.71x	45.67x
EV/Sales	95.98x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.08x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	216.5%	0.0%
Profitability
Gross Margin (TTM)	36.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-40M
FCF (TTM)	$-14M	$-21M
EPS (TTM)	-$21.10	-$2.66
ROE (TTM)	-44308.0%	-72989.0%
ROA (TTM)	-31311.0%	-29736.0%
ROIC (TTM)	-44308.0%	-72989.0%
Financial Health
Cash	$5M	$779K
Debt	$0	$0
Net Cash/Debt	$5M	$779K
Current Ratio (TTM)	2.61x	0.38x
Quick Ratio (TTM)	2.51x	0.27x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.81	-1.61
52W Performance	-75.3%	-93.1%
YTD Performance	-67.3%	-74.2%
% from 52W High	-76.8%	-93.8%
% from 52W Low	36.0%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.01x
FCF Yield (TTM)	-4.9%	-170.7%
Earnings Yield (TTM)	-11.1%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View GTBP research	View TPST research

Valuation

P/S Ratio

TPST

45.67x

GTBP

174.71x

EV/FCF

GTBP

-20.19x

TPST

-0.55x

Growth & revenue

Revenue Growth TTM

TPST

-6.3%

Forward Revenue Growth

GTBP

216.5%

TPST

0.0%

Profitability & performance

Gross Margin

GTBP

36.5%

TPST

0.0%

ROE

GTBP

-44308.0%

TPST

-72989.0%

FCF Yield %

GTBP

-4.9%

TPST

-170.7%

52-Week Performance

GTBP

-75.3%

TPST

-93.1%

Detailed metrics comparison

GTBP

GT Biopharma Inc

TPST

Tempest Therapeutics Inc

Market Cap

GTBP$296M

TPST$12M

Enterprise Value

GTBP$291M

TPST$11M

Price

GTBP$6.68

TPST$0.76

P/E Ratio

GTBPN/A

TPSTN/A

P/S Ratio

GTBP174.71x

TPST45.67x

EV/Sales

GTBP95.98x

TPST43.07x

EV/EBITDA

GTBP0.00x

TPST0.00x

P/B Ratio

GTBP3.08x

TPST16.67x

P/FCF Ratio

GTBPN/A

TPSTN/A

EV/FCF

GTBP-20.19x

TPST-0.55x

PEG Ratio

GTBPN/A

TPSTN/A

Forward P/E (NTM)

GTBPN/A

TPSTN/A

Forward P/S (NTM)

GTBPN/A

TPSTN/A

Revenue (TTM)

GTBP$0

TPST$0

Revenue Growth (YoY)

GTBPN/A

TPST-6.3%

Forward Rev Growth

GTBP216.5%

TPST0.0%

Gross Margin (TTM)

GTBP36.5%

TPST0.0%

Operating Margin (TTM)

GTBP0.0%

TPST0.0%

EBITDA Margin (TTM)

GTBP0.0%

TPST0.0%

Net Margin (TTM)

GTBP0.0%

TPST0.0%

FCF Margin (TTM)

GTBPN/A

TPSTN/A

Net Income (TTM)

GTBP$-33M

TPST$-40M

FCF (TTM)

GTBP$-14M

TPST$-21M

EPS (TTM)

GTBP-$21.10

TPST-$2.66

ROE (TTM)

GTBP-44308.0%

TPST-72989.0%

ROA (TTM)

GTBP-31311.0%

TPST-29736.0%

ROIC (TTM)

GTBP-44308.0%

TPST-72989.0%

Cash

GTBP$5M

TPST$779K

Debt

GTBP$0

TPST$0

Net Cash/Debt

GTBP$5M

TPST$779K

Current Ratio (TTM)

GTBP2.61x

TPST0.38x

Quick Ratio (TTM)

GTBP2.51x

TPST0.27x

Debt/Equity (TTM)

GTBP0.00x

TPST0.00x

Debt/Assets (TTM)

GTBP0.0%

TPST0.0%

Interest Coverage (TTM)

GTBPN/A

TPSTN/A

Net Debt/EBITDA (TTM)

GTBP0.00x

TPST0.00x

Beta

GTBP0.81

TPST-1.61

52W Performance

GTBP-75.3%

TPST-93.1%

YTD Performance

GTBP-67.3%

TPST-74.2%

% from 52W High

GTBP-76.8%

TPST-93.8%

% from 52W Low

GTBP36.0%

TPST2.3%

Asset Turnover (TTM)

GTBP0.08x

TPST0.01x

FCF Yield (TTM)

GTBP-4.9%

TPST-170.7%

Earnings Yield (TTM)

GTBP-11.1%

TPST-333.2%

Dividend Yield (TTM)

GTBPN/A

TPSTN/A

Rule of 40

GTBP0.0

TPST-6.3

EV/GP/RG

GTBPN/A

TPSTN/A

Ticker research

View GTBP research View TPST research

Metric	GTBP GT Biopharma Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$296M	$12M
Enterprise Value	$291M	$11M
Price	$6.68	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	174.71x	45.67x
EV/Sales	95.98x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.08x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-6.3%
Forward Rev Growth	216.5%	0.0%
Profitability
Gross Margin (TTM)	36.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-40M
FCF (TTM)	$-14M	$-21M
EPS (TTM)	-$21.10	-$2.66
ROE (TTM)	-44308.0%	-72989.0%
ROA (TTM)	-31311.0%	-29736.0%
ROIC (TTM)	-44308.0%	-72989.0%
Financial Health
Cash	$5M	$779K
Debt	$0	$0
Net Cash/Debt	$5M	$779K
Current Ratio (TTM)	2.61x	0.38x
Quick Ratio (TTM)	2.51x	0.27x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.81	-1.61
52W Performance	-75.3%	-93.1%
YTD Performance	-67.3%	-74.2%
% from 52W High	-76.8%	-93.8%
% from 52W Low	36.0%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.01x
FCF Yield (TTM)	-4.9%	-170.7%
Earnings Yield (TTM)	-11.1%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-6.3
EV/GP/RG	N/A	N/A
Ticker research	View GTBP research	View TPST research